期刊文献+

PEDF与喉鳞癌组织血管生成及临床病理因素的关系 被引量:1

Association of PEDF with Angiogenesis and Clinicopathological Factors of laryngeal Carcinoma
下载PDF
导出
摘要 目的探讨色素上皮衍生因子(PEDF)在喉癌组织血管生成中的作用及PEDF与喉癌临床病理因素的关系。方法用免疫组织化学法检测42例人体喉鳞癌标本和11例正常喉黏膜组织中PEDF和血管内皮生长因子(VEGF)的表达,标记内皮细胞黏附分子(CD31)分子显示血管内皮细胞,并计数上述喉鳞癌组织内的微血管密度;统计学分析上述分子标记物间的关系以及各分子标记物与喉鳞癌临床病理因素间的关系。结果所有的正常喉黏膜(11例)均有PEDF表达,喉鳞癌组织PEDF表达率47%(20/42),VEGF表达率57%(24/42),淋巴结转移者呈现PEDF低表达,表达率14%(6/42)(P<0.01);喉癌组织中PEDF的表达与微血管密度(MVD)(P<0.01)和VEGF(P<0.01)的表达呈负相关关系,VEGF表达与MVD呈正相关关系(P<0.01)。结论PEDF低表达和VEGF高表达可能是喉鳞癌组织内微血管生成的分子基础,是促进喉鳞癌细胞发生淋巴及血管转移的重要因素。 Objective To investigate the role of PEDF in angiogenesis and association of PEDF expression with clinicopathological factors in laryngeal carcinoma. Methods SABC immunohistochemistry method was used to detect the expression of PEDF and VEGF in 42 cases of laryngeal carcinoma and in 11 cases of laryngeal normal tissue samples. CD31 was used to endothelial cells and the MVD was calculated. The relationship between the molecular markers and the relationship between the markers and clinicopathological factors of laryngeal carcinoma were analyzed by statistical method. Results PEDF expression was showed in all normal(ll cases) laryngeal mucous menbrane. The positive rate of PEDF and VEGF were 47% (20/42)and 57%(24/42) in laryngeal carcinoma Compared with well-differentiated laryngeal cancer. The laryngeal carcinoma cells with lower PEDF expression tend to metastases by lymphatic vessels and the positive rate were 14%(6/42) (P〈0. 01). There were negative correlation between PEDF and MVD (P〈0. 01), VEGF (P〈 0.01) and positive correlation between VEGF and MVD (P〈 0. 01). Conclusion Lower PEDF and higher VEGF expression might be the molecular basis of angiogenesis in laryngeal carcinoma tissue and play an important role in lymphatic and blood metastasis of laryngeal carcinoma.
出处 《贵州医药》 CAS 2007年第3期221-223,共3页 Guizhou Medical Journal
关键词 喉鳞癌 色素上皮衍生因子 血管内皮生长因子 微血管密度 laryngeal neoolasm PEDF VEGF MVD
  • 相关文献

参考文献10

  • 1Dawsond W,Volperto V,Gillis P,et al.Pigment epithe Lium-derived factor:a potent inhibitor of angiogenesis[J].Science,1999,285(5 425):245-248.
  • 2方建晨,邵春奎,苏祖兰.色素上皮源性因子与肿瘤[J].国外医学(生理病理科学与临床分册),2004,24(3):283-285. 被引量:3
  • 3DolL J A,Stellmach V M,Bouck N P,et al.Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas[J].Nat Med,2003,9(6):774-780.
  • 4Crawford S E,Stellmach V,Ranalli M,et al.Pigment epithelium-derived factor(PEDF)in neuroblastoma:a multifunctional mediator of Schwann cell antitumor activity[J].J Cell Sci,2001,114(24):4 421-4 428.
  • 5Guan M,Yam H F,SuB,et al.Loss of pigment epithelium derived factor expression in glioma progression[J].J Clin Pathol,2003,56(4):277-282.
  • 6Quan G M,Ojaimi J,Nadesapillai A P,et al.Resistance of epiphyseal cartilage to invasion by osteosareoma is likely to be due to expression of antiangiogenic factors[J].Pathobiology,2003,70(6):361-367.
  • 7Weidner N.Intratumor microvessel density as a prognostic fsctor in cancer[J].Am J Pathol,1995,147:9.
  • 8VolperT O V,Zaichuk T,Zhou W,et al.Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-land pigment epithelium-derived factor[J].Nat Med,2002,8(4):349-357.
  • 9Abramson L P,Stellmach V,Doll J A,et al.Wilms'tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model[J].J Pediatr Surg,2003,38(3):336-342.
  • 10Stoeltzing O,Ellis L,M Regulators of vascular endothelial growth factor expression in cancer[J].Cancer Trear Res,2004,119:33-58.

二级参考文献19

  • 1Simonovic M, Gettins PG, Volz K. Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor[J]. Proc Natl Acad Sci, 2001,98:11131-11135.
  • 2Stellmach V, Crawford SE, Zhou W,et al. Prevention of isehemiainduced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor[ J~. Proc Natl Acad Sci,2001,98 ( 5 ) :2593-2597.
  • 3Doll JA, Stellmach VM, Bouck NP,et al. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas[J]. Nat Med,2003,9(6) :774-780.
  • 4Abramson LP, Stellmach V, Doll JA ,et al. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model[ J ]. J Pediatr Surg,2003,38 (3) :336-342.
  • 5Rasmussen H, Chu KW, Campochiaro P, et al. Clinical protocol.An open-label, phase I, single administration, dose-escalation study of ADGVPEDF. 11D (ADPEDF) in neovascular age-related macular degeneration ( AMD ) [ J ]. Hum Gene Ther, 2001, 12 (16) :2029-2032.
  • 6Volpert OV, Zaichuk T, Zhou W,et al. Inducer-stlmulated Fas targets activated endothelium for destruction by anti-angiogenic thrumbospondin-1 and pigment epithelium-derived factor[J]. Nat Med,2002,8(4) :349-357.
  • 7Wang L,Schmitz V, Perez-Mediavilla A,et al. Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor[ J ]. Mol Ther, 2003,8 ( 1 ) : 72-79.
  • 8Guan M, Yam HF, Su B,et al. Loss of pigment epithelium derived factor expression in glioma progression[J]. J Clin Pathol,2003,56 (4) :277-282.
  • 9Palmieri D, Watson JM, Rinehart CA. Age-related expression of PEDF/EPC-I in human endometrial stromal fibroblasts: implications for interactive senescence [ J 1. Exp Cell Res, 1999,247 ( 1 ) :142-147.
  • 10Quan GM, Ojaimi J, Nadesapillai AP,et al. Resistance of epiphyseal cartilage to invasion by osteosareoma is likely to be due to expression of antiangiogenic factors [ J 1. Pathobiology,2003,70 ( 6 ) :361-367.

共引文献2

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部